Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Torrent Pharma says promoters havent pledged shares

      Torrent Pharma says promoters haven't pledged shares

      Medical Dialogues Bureau6 April 2020 11:45 AM IST
      New Delhi: Torrent Pharma has said that its promoters have not pledged any equity shares they hold in the company for any purpose, and a surveillance...
      Govt tightens export ban norms for anti-malarial drug hydroxychloroquine

      Govt tightens export ban norms for anti-malarial drug hydroxychloroquine

      Medical Dialogues Bureau6 April 2020 10:00 AM IST
      New Delhi: The government has tightened the export ban norms on anti-malarial drug hydroxychloroquine by including special economic zones (SEZs) under...
      USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

      USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market

      Medical Dialogues Bureau6 April 2020 9:15 AM IST
      The U.S. Food and Drug Administration has announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine...
      Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

      Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus

      Medical Dialogues Bureau5 April 2020 2:41 PM IST
      Mumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol...
      CDSCO releases procedure for lot release of Human vaccine in view of prevailing COVID-19 pandemic

      CDSCO releases procedure for lot release of Human vaccine in view of prevailing COVID-19 pandemic

      Medical Dialogues Bureau5 April 2020 2:19 PM IST
      New Delhi: Through the recent circular Central Drugs Standard Control Organisation(CDSCO), Directorate General of Health Services has stated the...
      Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)

      Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab)

      Medical Dialogues Bureau5 April 2020 2:15 PM IST
      New York: Pfizer Inc. has announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody (mAb) and biosimilar...
      Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India

      Thermo Fisher Scientific to enhance capacity for COVID-19 testing in India

      Medical Dialogues Bureau5 April 2020 2:07 PM IST
      Mumbai: Thermo Fisher Scientific Inc., the world leader in serving science, is accelerating its efforts with diagnostic testing and vaccine...
      DeepTek Medical Imaging collaborates with Japanese MBM for AI- lead solution to screen Coronavirus

      DeepTek Medical Imaging collaborates with Japanese MBM for AI- lead solution to screen Coronavirus

      Medical Dialogues Bureau5 April 2020 11:00 AM IST
      Pune: Recently there have been notable developments in health tech diagnostics due to Artificial Intelligence tools for analyzing medical scans like...
      Bristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDA

      Bristol Myers Squibb, bluebird bio announce submission of BLA for Myeloma Drug to USFDA

      Medical Dialogues Bureau4 April 2020 2:09 PM IST
      BCMA is a protein that is nearly universally expressed on cancer cells in multiple myeloma, making it an important potential target for the treatment...
      Lupin gets USFDA EIR for Aurangabad Facility

      Lupin gets USFDA EIR for Aurangabad Facility

      Medical Dialogues Bureau4 April 2020 1:38 PM IST
      Mumbai: Pharma major Lupin Limited (Lupin) has announced the receipt of the Establishment Inspection Report (EIR) from the U.S. FDA for its...
      HUL completes GSK merger, buys Horlicks in Rs 3,045 crores

      HUL completes GSK merger, buys Horlicks in Rs 3,045 crores

      Medical Dialogues Bureau4 April 2020 1:36 PM IST
      Horlicks has a volume share of close to 50 per cent in the HFD market
      AstraZeneca divestment of Movantik to RedHill Biopharma completed

      AstraZeneca divestment of Movantik to RedHill Biopharma completed

      Medical Dialogues Bureau4 April 2020 11:00 AM IST
      UK: AstraZeneca has completed the previously communicated agreement to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok